Mridul Agrawal is a physician-scientist and entrepreneur, serving as Co-Founder and CEO of iuvando Health, a company revolutionizing cancer care through personalized clinical trial matching. Leveraging his expertise in medicine and innovation, Dr. Agrawal leads iuvando Health to bridge the gap between patients and life-saving clinical trials, ensuring access to cutting-edge treatments. Before founding iuvando Health, Dr. Agrawal trained as a physician-scientist with a focus on oncology and translational medicine at Dana-Farber Cancer Institute and Harvard Medical School in Boston, USA. His passion for personalized care stems from years of working directly with patients, driving his commitment to innovative, patient-centric solutions. Dr. Agrawal is also an advocate for advancing cancer research, participating in international forums, and emphasizing the importance of collaboration in healthcare innovation. Born and raised in Germany to Indian immigrant parents, Dr. Agrawal combines a global perspective with a deep commitment to improving healthcare systems. He holds degrees in medicine (M.D.) and health economics (M.Sc.) from Heidelberg University, Germany.